Non-overt disseminated intravascular coagulation scoring for critically ill patients: The impact of antithrombin levels

Moritoki Egi, Hiroshi Morimatsu, Christian J. Wiedermann, Makiko Tani, Tomoyuki Kanazawa, Satoshi Suzuki, Takashi Matsusaki, Kazuyoshi Shimizu, Yuichiro Toda, Tatsuo Iwasaki, Kiyoshi Morita

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Validation of a scoring algorithm for non-overt disseminated intravascular coagulation (DIC) proposed by the International Society on Thrombosis and Haemostasis (ISTH) is still incomplete. It was the objective of this study to assess the impact of including AT to non-overt DIC scoring on the predictability for intensive care unit (ICU) death and the later development of overt- DIC defined by the Japanese Ministry of Health and Welfare (JMHW) or the ISTH. We performed a retrospective observational study conducted in 364 patients in critical care. Coagulation parameters obtained daily for DIC screening were utilised for scoring. There were 194 and 196 patients scored as positive non-overt DIC with and without AT, respectively; diagnostic agreement between the two was 78%. As compared with patients without non-overt DIC, these non-overt DIC patients had significantly higher mortality. In 37 ICU non-survivors, positive non-overt DIC scoring with AT preceded ICU death by a median of 6.8 days, which was significantly earlier as compared with a median of 5.4 days for non-overt DIC without AT (p=0.022). In patients who developed overt-DIC after admission, the time period from positive non-overt DIC to positive overt-DIC was significantly longer when AT was utilised (overt- DIC ISTH; 1.3 days vs. 0.1 days, p=0.004, overt-DIC JMHW; 2.5 days vs. 2.0 days, p=0.04, with AT vs. without AT, respectively). Non-overt DIC scoring predicted a high risk of death in critically ill patients. When information on AT levels was included, nonovert DIC scoring was found to predict development of overt- DIC significantly earlier than non-overt DIC scoring without AT.

Original languageEnglish
Pages (from-to)696-705
Number of pages10
JournalThrombosis and Haemostasis
Volume101
Issue number4
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Antithrombins
Disseminated Intravascular Coagulation
Critical Illness
Hemostasis
Intensive Care Units
Thrombosis
Health

Keywords

  • Antithrombin
  • Disseminated intravascular coagulation
  • International Society on Thrombosis and Haemostasis
  • Predictability
  • Validation

ASJC Scopus subject areas

  • Hematology

Cite this

@article{d694632b344043109e7d2af8cdb07ec0,
title = "Non-overt disseminated intravascular coagulation scoring for critically ill patients: The impact of antithrombin levels",
abstract = "Validation of a scoring algorithm for non-overt disseminated intravascular coagulation (DIC) proposed by the International Society on Thrombosis and Haemostasis (ISTH) is still incomplete. It was the objective of this study to assess the impact of including AT to non-overt DIC scoring on the predictability for intensive care unit (ICU) death and the later development of overt- DIC defined by the Japanese Ministry of Health and Welfare (JMHW) or the ISTH. We performed a retrospective observational study conducted in 364 patients in critical care. Coagulation parameters obtained daily for DIC screening were utilised for scoring. There were 194 and 196 patients scored as positive non-overt DIC with and without AT, respectively; diagnostic agreement between the two was 78{\%}. As compared with patients without non-overt DIC, these non-overt DIC patients had significantly higher mortality. In 37 ICU non-survivors, positive non-overt DIC scoring with AT preceded ICU death by a median of 6.8 days, which was significantly earlier as compared with a median of 5.4 days for non-overt DIC without AT (p=0.022). In patients who developed overt-DIC after admission, the time period from positive non-overt DIC to positive overt-DIC was significantly longer when AT was utilised (overt- DIC ISTH; 1.3 days vs. 0.1 days, p=0.004, overt-DIC JMHW; 2.5 days vs. 2.0 days, p=0.04, with AT vs. without AT, respectively). Non-overt DIC scoring predicted a high risk of death in critically ill patients. When information on AT levels was included, nonovert DIC scoring was found to predict development of overt- DIC significantly earlier than non-overt DIC scoring without AT.",
keywords = "Antithrombin, Disseminated intravascular coagulation, International Society on Thrombosis and Haemostasis, Predictability, Validation",
author = "Moritoki Egi and Hiroshi Morimatsu and Wiedermann, {Christian J.} and Makiko Tani and Tomoyuki Kanazawa and Satoshi Suzuki and Takashi Matsusaki and Kazuyoshi Shimizu and Yuichiro Toda and Tatsuo Iwasaki and Kiyoshi Morita",
year = "2009",
month = "4",
doi = "10.1160/TH08-07-0448",
language = "English",
volume = "101",
pages = "696--705",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "4",

}

TY - JOUR

T1 - Non-overt disseminated intravascular coagulation scoring for critically ill patients

T2 - The impact of antithrombin levels

AU - Egi, Moritoki

AU - Morimatsu, Hiroshi

AU - Wiedermann, Christian J.

AU - Tani, Makiko

AU - Kanazawa, Tomoyuki

AU - Suzuki, Satoshi

AU - Matsusaki, Takashi

AU - Shimizu, Kazuyoshi

AU - Toda, Yuichiro

AU - Iwasaki, Tatsuo

AU - Morita, Kiyoshi

PY - 2009/4

Y1 - 2009/4

N2 - Validation of a scoring algorithm for non-overt disseminated intravascular coagulation (DIC) proposed by the International Society on Thrombosis and Haemostasis (ISTH) is still incomplete. It was the objective of this study to assess the impact of including AT to non-overt DIC scoring on the predictability for intensive care unit (ICU) death and the later development of overt- DIC defined by the Japanese Ministry of Health and Welfare (JMHW) or the ISTH. We performed a retrospective observational study conducted in 364 patients in critical care. Coagulation parameters obtained daily for DIC screening were utilised for scoring. There were 194 and 196 patients scored as positive non-overt DIC with and without AT, respectively; diagnostic agreement between the two was 78%. As compared with patients without non-overt DIC, these non-overt DIC patients had significantly higher mortality. In 37 ICU non-survivors, positive non-overt DIC scoring with AT preceded ICU death by a median of 6.8 days, which was significantly earlier as compared with a median of 5.4 days for non-overt DIC without AT (p=0.022). In patients who developed overt-DIC after admission, the time period from positive non-overt DIC to positive overt-DIC was significantly longer when AT was utilised (overt- DIC ISTH; 1.3 days vs. 0.1 days, p=0.004, overt-DIC JMHW; 2.5 days vs. 2.0 days, p=0.04, with AT vs. without AT, respectively). Non-overt DIC scoring predicted a high risk of death in critically ill patients. When information on AT levels was included, nonovert DIC scoring was found to predict development of overt- DIC significantly earlier than non-overt DIC scoring without AT.

AB - Validation of a scoring algorithm for non-overt disseminated intravascular coagulation (DIC) proposed by the International Society on Thrombosis and Haemostasis (ISTH) is still incomplete. It was the objective of this study to assess the impact of including AT to non-overt DIC scoring on the predictability for intensive care unit (ICU) death and the later development of overt- DIC defined by the Japanese Ministry of Health and Welfare (JMHW) or the ISTH. We performed a retrospective observational study conducted in 364 patients in critical care. Coagulation parameters obtained daily for DIC screening were utilised for scoring. There were 194 and 196 patients scored as positive non-overt DIC with and without AT, respectively; diagnostic agreement between the two was 78%. As compared with patients without non-overt DIC, these non-overt DIC patients had significantly higher mortality. In 37 ICU non-survivors, positive non-overt DIC scoring with AT preceded ICU death by a median of 6.8 days, which was significantly earlier as compared with a median of 5.4 days for non-overt DIC without AT (p=0.022). In patients who developed overt-DIC after admission, the time period from positive non-overt DIC to positive overt-DIC was significantly longer when AT was utilised (overt- DIC ISTH; 1.3 days vs. 0.1 days, p=0.004, overt-DIC JMHW; 2.5 days vs. 2.0 days, p=0.04, with AT vs. without AT, respectively). Non-overt DIC scoring predicted a high risk of death in critically ill patients. When information on AT levels was included, nonovert DIC scoring was found to predict development of overt- DIC significantly earlier than non-overt DIC scoring without AT.

KW - Antithrombin

KW - Disseminated intravascular coagulation

KW - International Society on Thrombosis and Haemostasis

KW - Predictability

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=64849097798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64849097798&partnerID=8YFLogxK

U2 - 10.1160/TH08-07-0448

DO - 10.1160/TH08-07-0448

M3 - Article

C2 - 19350114

AN - SCOPUS:64849097798

VL - 101

SP - 696

EP - 705

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 4

ER -